We are live on
!
Find out more
PCH
Polar Capital Holdings Portfolio holdings
AUM
$42.4B
1-Year Est. Return
181.11%
This Fund
S&P 500
This Quarter
Est. Return
-0.56%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
–
AUM
$15.7B
AUM Growth
-$1.33B
(-7.8%)
Cap. Flow
-$153M
Cap. Flow
% of AUM
-0.98%
Top 10 Holdings %
Top 10 Hldgs %
39.89%
Holding
471
New
38
Increased
139
Reduced
173
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$70.7M |
| 2 |
Meta Platforms (Facebook)
META
|
+$66.5M |
| 3 |
Becton Dickinson
BDX
|
+$61.6M |
| 4 |
GitLab
GTLB
|
+$58.7M |
| 5 |
Teradyne
TER
|
+$58.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$85.2M |
| 2 |
Steris
STE
|
+$78.2M |
| 3 |
CVS Health
CVS
|
+$62.9M |
| 4 |
Neurocrine Biosciences
NBIX
|
+$61.9M |
| 5 |
FIVE9
FIVN
|
+$58.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.08% |
| 2 | Industrials | 22.24% |
| 3 | Healthcare | 19.2% |
| 4 | Financials | 15.72% |
| 5 | Communication Services | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Regeneron Pharmaceuticals
REGN
$80.5B
| $77.5M | 0.49% |
112,500
-12,500
| -10% | -$7.87M |
|
52
Progressive
PGR
$126B
| $77.3M | 0.49% |
665,000
+10,000
| +2% | +$1.2M |
|
53
Incyte
INCY
$24.8B
| $77.2M | 0.49% |
1,158,298
+207,258
| +22% | +$15.3M |
|
54
Everest Group
EG
$14.3B
| $76.1M | 0.49% |
290,000
+20,000
| +7% | +$5.41M |
|
55
SolarEdge
SEDG
$2.17B
| $75.1M | 0.48% |
324,384
+31,554
| +11% | +$9.31M |
|
56
Molina Healthcare
MOH
$10.7B
| $73.5M | 0.47% |
222,899
-5,165
| -2% | -$1.66M |
|
57
Alibaba
BABA
$272B
| $69.8M | 0.44% |
872,958
-354,824
| -29% | -$33.8M |
|
58
Snowflake
SNOW
$117B
| $68.7M | 0.44% |
404,174
-205,517
| -34% | -$34M |
|
59
Penumbra
PEN
$12.5B
| $67.9M | 0.43% |
358,147
+341,346
| +2,032% | +$54.8M |
|
|
60
DexCom
DXCM
$31.3B
| $67.2M | 0.43% |
+834,956
| New | +$70.7M |
|
61
United Therapeutics
UTHR
$21.3B
| $67.2M | 0.43% |
320,831
+15,678
| +5% | +$3.51M |
|
62
Option Care Health
OPCH
$3.52B
| $67.2M | 0.43% |
2,134,020
+393,500
| +23% | +$12.6M |
|
63
Biogen
BIIB
$32.1B
| $66.8M | 0.43% |
250,000
+75,000
| +43% | +$15.9M |
|
|
SMAR
64
DELISTED
Smartsheet Inc.
SMAR
| $65.4M | 0.42% |
1,903,245
+646,650
| +51% | +$21.9M |
|
65
Salesforce
CRM
$214B
| $63.9M | 0.41% |
443,991
-251,020
| -36% | -$42.6M |
|
66
Workday
WDAY
$44.8B
| $59.1M | 0.38% |
388,473
+154,951
| +66% | +$24.3M |
|
67
Cloudflare
NET
$118B
| $57.8M | 0.37% |
1,044,199
+736,578
| +239% | +$43.7M |
|
68
Synopsys
SNPS
$73.1B
| $57.2M | 0.36% |
187,103
-88,510
| -32% | -$30M |
|
69
Globant
GLOB
$1.63B
| $56.7M | 0.36% |
303,087
+221,834
| +273% | +$45.7M |
|
|
70
Becton Dickinson
BDX
$48.4B
| $55.2M | 0.35% |
+247,586
| New | +$61.6M |
|
71
Johnson & Johnson
JNJ
$642B
| $53.1M | 0.34% |
324,804
+34,229
| +12% | +$5.79M |
|
|
72
GitLab
GTLB
$8.21B
| $51.5M | 0.33% |
+1,006,043
| New | +$58.7M |
|
|
AXNX
73
DELISTED
Axonics, Inc. Common Stock
AXNX
| $50M | 0.32% |
710,336
| – | – |
|
74
Analog Devices
ADI
$175B
| $49.9M | 0.32% |
358,453
+186,490
| +108% | +$29.5M |
|
75
First American
FAF
$7.33B
| $48.4M | 0.31% |
1,050,000
+50,000
| +5% | +$2.7M |
|
Similar funds
GAM
SAM
Polar Capital Holdings's Q3 2022 Portfolio in Review
As of Q3 2022, Polar Capital Holdings held 471 positions worth $15.7B, down 7.8% from $17B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Polar Capital Holdings's Q3 2022 filing shows 38 new, 139 increased, 173 reduced and 54 closed positions. Its largest new stake was DexCom: 834,956 shares worth $67.2M. The largest sale was Adobe, an estimated $85.2M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Industrials and Healthcare.
- Polar Capital Holdings's largest Q3 2022 buy was DexCom: 834,956 shares worth $67.2M.
- Polar Capital Holdings added most to Meta Platforms (Facebook) in Q3 2022, an estimated $66.5M increase.
- Polar Capital Holdings's biggest Q3 2022 reduction was Neurocrine Biosciences, cutting an estimated $61.9M.
- Polar Capital Holdings fully exited Adobe in Q3 2022, selling an estimated $85.2M.
- Polar Capital Holdings's ten largest holdings make up 40% of its $15.7B portfolio in Q3 2022.
- Polar Capital Holdings opened 38 new positions and closed 54 in Q3 2022.
- Polar Capital Holdings's portfolio value fell 7.8% quarter-over-quarter to $15.7B.
Based on Polar Capital Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.